72 related articles for article (PubMed ID: 29941221)
1. TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD-A Novel Presentation.
Gulati A; Bale AE; Dykas DJ; Bia MJ; Danovitch GM; Moeckel GW; Somlo S; Dahl NK
Am J Kidney Dis; 2018 Dec; 72(6):895-899. PubMed ID: 29941221
[TBL] [Abstract][Full Text] [Related]
2. Inherited C-terminal TREX1 variants disrupt homology-directed repair to cause senescence and DNA damage phenotypes in Drosophila, mice, and humans.
Chauvin SD; Ando S; Holley JA; Sugie A; Zhao FR; Poddar S; Kato R; Miner CA; Nitta Y; Krishnamurthy SR; Saito R; Ning Y; Hatano Y; Kitahara S; Koide S; Stinson WA; Fu J; Surve N; Kumble L; Qian W; Polishchuk O; Andhey PS; Chiang C; Liu G; Colombeau L; Rodriguez R; Manel N; Kakita A; Artyomov MN; Schultz DC; Coates PT; Roberson EDO; Belkaid Y; Greenberg RA; Cherry S; Gack MU; Hardy T; Onodera O; Kato T; Miner JJ
Nat Commun; 2024 Jun; 15(1):4696. PubMed ID: 38824133
[TBL] [Abstract][Full Text] [Related]
3. Measuring TREX1 and TREX2 exonuclease activities.
Hemphill WO; Perrino FW
Methods Enzymol; 2019; 625():109-133. PubMed ID: 31455522
[TBL] [Abstract][Full Text] [Related]
4. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome.
Rice G; Newman WG; Dean J; Patrick T; Parmar R; Flintoff K; Robins P; Harvey S; Hollis T; O'Hara A; Herrick AL; Bowden AP; Perrino FW; Lindahl T; Barnes DE; Crow YJ
Am J Hum Genet; 2007 Apr; 80(4):811-5. PubMed ID: 17357087
[TBL] [Abstract][Full Text] [Related]
5. The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease.
Lehtinen DA; Harvey S; Mulcahy MJ; Hollis T; Perrino FW
J Biol Chem; 2008 Nov; 283(46):31649-56. PubMed ID: 18805785
[TBL] [Abstract][Full Text] [Related]
6. Genetic, clinical, and pathological study of patients with severe hypertension-associated renal microangiopathy.
Chen X; Zhang X; Wang Y; Wang S; Zhao M
J Nephrol; 2023 Dec; 36(9):2477-2490. PubMed ID: 37103770
[TBL] [Abstract][Full Text] [Related]
7. Fruquintinib-induced renal-limited thrombotic microangiopathy: a case report.
Zhao R; Fan R; Pan Y; Han Y; Wang Y; Chen W
BMC Nephrol; 2024 May; 25(1):170. PubMed ID: 38762494
[TBL] [Abstract][Full Text] [Related]
8. Retinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations: Critical Role of Retina Specialists.
Houghton OM; Carter J; Dhamija R
J Vitreoretin Dis; 2023; 7(2):171-177. PubMed ID: 37006667
[TBL] [Abstract][Full Text] [Related]
9. Molecular insight into the specific enzymatic properties of TREX1 revealing the diverse functions in processing RNA and DNA/RNA hybrids.
Huang KW; Wu CY; Toh SI; Liu TC; Tu CI; Lin YH; Cheng AJ; Kao YT; Chu JW; Hsiao YY
Nucleic Acids Res; 2023 Nov; 51(21):11927-11940. PubMed ID: 37870446
[TBL] [Abstract][Full Text] [Related]
10. Kidney-Predominant Thrombotic Microangiopathy Associated With
Song ZR; Jiang L; Li Y; Xiang CG; Liu ZY; Li MS; Zhang H; Zhou XJ
Kidney Int Rep; 2023 Oct; 8(10):2172-2176. PubMed ID: 37850007
[No Abstract] [Full Text] [Related]
11. Complement-mediated thrombotic microangiopathy on a background of Alport syndrome: A case report.
Coorey CP; de Malmanche T; Chou A; Feddersen M
Nephrology (Carlton); 2024 Apr; ():. PubMed ID: 38604610
[TBL] [Abstract][Full Text] [Related]
12. Three prime repair exonuclease 1 preferentially degrades the integration-incompetent HIV-1 DNA through favorable kinetics, thermodynamic, structural, and conformational properties.
Prakash P; Khodke P; Balasubramaniam M; Davids BO; Hollis T; Davis J; Kumbhar B; Dash C
J Biol Chem; 2024 Jun; 300(7):107438. PubMed ID: 38838778
[TBL] [Abstract][Full Text] [Related]
13. Three Prime Repair Exonuclease 1 preferentially degrades the integration-incompetent HIV-1 DNA through favorable kinetics, thermodynamic, structural and conformational properties.
Prakash P; Khodke P; Balasubramaniam M; Davids BO; Hollis T; Davis J; Pandhare J; Kumbhar B; Dash C
bioRxiv; 2024 Mar; ():. PubMed ID: 38562877
[TBL] [Abstract][Full Text] [Related]
14. Role of the I416L Variant of Complement Factor I in Thrombotic Microangiopathy Among Patients of African Ancestry.
Nobile G; Doreille A; Raymond L; Robert T; Dancer M; Mesnard L; Rafat C
Kidney Int Rep; 2023 Oct; 8(10):2136-2140. PubMed ID: 37849999
[No Abstract] [Full Text] [Related]
15. Familial chilblain lupus with TREX1 mutation and cerebrovascular disease.
Nohara T; Yanagi T; Yabe I; Ota N; Kanazawa N; Ujiie H; Kosumi H; Mai Y; Shimizu H
Lancet Rheumatol; 2020 Nov; 2(11):e724. PubMed ID: 38279366
[No Abstract] [Full Text] [Related]
16. Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
Kato H; Miyakawa Y; Hidaka Y; Inoue N; Ito S; Kagami S; Kaname S; Matsumoto M; Mizuno M; Matsuda T; Shimono A; Maruyama S; Fujimura Y; Nangaku M; Okada H
Clin Exp Nephrol; 2019 Jan; 23(1):65-75. PubMed ID: 29959568
[TBL] [Abstract][Full Text] [Related]
17. Systemic features of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel disease.
Pelzer N; Hoogeveen ES; Haan J; Bunnik R; Poot CC; van Zwet EW; Inderson A; Fogteloo AJ; Reinders MEJ; Middelkoop HAM; Kruit MC; van den Maagdenberg AMJM; Ferrari MD; Terwindt GM
J Intern Med; 2019 Mar; 285(3):317-332. PubMed ID: 30411414
[TBL] [Abstract][Full Text] [Related]
18. TREX1 As a Potential Therapeutic Target for Autoimmune and Inflammatory Diseases.
Tao SS; Wu GC; Zhang Q; Zhang TP; Leng RX; Pan HF; Ye DQ
Curr Pharm Des; 2019; 25(30):3239-3247. PubMed ID: 31475890
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
